Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge

JOURNAL ARTICLE published 1 November 2020 in JAMA Oncology

Authors: Jie Liu | Jinming Yu | Xue Meng

Highlights

JOURNAL ARTICLE published 1 April 2019 in JAMA Oncology

Incorrect Email Address for Corresponding Author

JOURNAL ARTICLE published 1 July 2018 in JAMA Oncology

Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?

JOURNAL ARTICLE published 1 August 2019 in JAMA Oncology

Authors: Stephen G. Chun | Steven E. Schild | Jeffrey A. Bogart

Small Cell, Large Impact

JOURNAL ARTICLE published 1 November 2017 in JAMA Oncology

Authors: Amishi Bajaj

Brain Lesion in the Setting of Chronic Rituximab Treatment

JOURNAL ARTICLE published 1 July 2020 in JAMA Oncology

Authors: Milad Yazdani | Michael Antonucci | Maria Vittoria Spampinato

Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer—Reply

JOURNAL ARTICLE published 1 May 2020 in JAMA Oncology

Authors: Sarah S. Jackson | Ruth M. Pfeiffer | Jill Koshiol

Oregon’s Death With Dignity Act—Reply

JOURNAL ARTICLE published 1 May 2018 in JAMA Oncology

Authors: Charles Blanke | Lee Ellis | Frank Meyskens

Immune-Related Adverse Events—A Novel Prediction of Nivolumab Efficacy?—Reply

JOURNAL ARTICLE published 1 July 2018 in JAMA Oncology

Authors: Koji Haratani | Hidetoshi Hayashi | Kazuhiko Nakagawa

Additional Factors in the Association of Gender and Parenthood With Conference Attendance—Reply

JOURNAL ARTICLE published 1 January 2020 in JAMA Oncology

Authors: Miriam A. Knoll | Reshma Jagsi

Framing New Models to Expand Access to Radiotherapy in Limited Resource Settings—Social Entrepreneurship

JOURNAL ARTICLE published 1 February 2020 in JAMA Oncology

Authors: Omoruyi C. Irabor | Benjamin C. Li | Oluwadamilola T. Oladeru

Is 2045 Optimistic?—Concerns Regarding Rising Vaccine Hesitancy—Reply

JOURNAL ARTICLE published 1 March 2022 in JAMA Oncology

Authors: Yuehan Zhang | Carole Fakhry | Gypsyamber D’Souza

Forging New Strategies in the Cure of Human Oligometastatic Cancer

JOURNAL ARTICLE published 1 May 2020 in JAMA Oncology

Authors: Carlo Greco | Zvi Fuks

Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma—Reply

JOURNAL ARTICLE published 1 January 2019 in JAMA Oncology

Authors: Ulrich Mansmann | Lars H. Lindner | Rolf Issels

Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays

JOURNAL ARTICLE published 1 October 2018 in JAMA Oncology

Authors: Samuel V. Angiuoli | James R. White | Siân Jones

The Floor Is Not Stable

JOURNAL ARTICLE published 1 January 2018 in JAMA Oncology

Authors: Marjorie S. Rosenthal

Role of Patient-Reported Outcome Measures in the Inpatient Setting

JOURNAL ARTICLE published 1 September 2022 in JAMA Oncology

Authors: Abdulla Al-Rashdan

Diffuse Hyperpigmentation in a Patient With an Axillary Mass

JOURNAL ARTICLE published 1 August 2019 in JAMA Oncology

Authors: Shruti Bhandari | Prashant Tripathi | Hamza Hashmi

Prostate Cancer Screening—A New Recommendation for Meaningful Physician-Patient Conversations

JOURNAL ARTICLE published 1 August 2018 in JAMA Oncology

Authors: Anita D. Misra-Hebert | Michael W. Kattan

Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non–Small Cell Lung Cancer

JOURNAL ARTICLE published 1 January 2022 in JAMA Oncology

Authors: Lu Tian | Bo Huang | Lee-Jen Wei